Sarepta 治療公司
US ˙ NasdaqGS ˙ US8036071004

SecuritySRPT / Sarepta Therapeutics, Inc.
InstitutionWestpac Banking Corp
Latest Disclosed Ownership7,173 shares
Latest Disclosed Value $ 156,084
Westpac Banking Corp ownership in SRPT / Sarepta Therapeutics, Inc.

On May 11, 2026 - Westpac Banking Corp filed a 13F-HR form disclosing ownership of 7,173 shares of Sarepta Therapeutics, Inc. (US:SRPT) valued at $156,084 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 7,173 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $119,502 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 7,173 0 0.00 156 1.30 0.0054
2026-02-10 2025-12-31 13F SAREPTA THERAPEUTICS INC USD 0.0001 COM 803607100 7,173 7,173 154 0.0098
2021-08-10 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 0 -6,319 -100.00 0 -100.00
2021-05-13 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 6,319 0 0.00 471 -56.36 0.0052
2021-02-11 2020-12-31 13F SAREPTA THERAPEUTICS COM 803607100 6,319 0 0.00 1,077 21.42 0.0122
2020-11-10 2020-09-30 13F SAREPTA THERAPEUTICS COM 803607100 6,319 0 0.00 887 -12.44 0.0120
2020-08-12 2020-06-30 13F SAREPTA THERAPEUTICS COM 803607100 6,319 0 0.00 1,013 63.92 0.0151
2020-05-14 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 6,319 0 0.00 618 -24.17 0.0107
2020-02-11 2019-12-31 13F SAREPTA THERAPEUTICS COM 803607100 6,319 0 0.00 815 71.58 0.0105
2019-11-13 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 6,319 6,319 476 0.0066
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.